U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07160075) titled 'HIV Prevention With PrEP Among People on Opioid Replacement Therapy' on Aug. 18.
Brief Summary: The purpose of this study is to assess the feasibility and acceptability of providing oral pre-exposure prophylaxis (PrEP) and opioid agonist therapy (OAT) simultaneously in existing pharmacy-based programs operating in Alberta and Saskatchewan, to collect preference, adherence, and persistence data on oral PrEP, and to assess interest / acceptability of long-lasting injectable options for human immunodeficiency virus (HIV) prevention.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
HIV - Human Immunodeficiency Virus...